Health Canada drug identification number

DIN 02412683 — NAGLAZYME 1 MG

NAGLAZYME is a solution of Galsulfase marketed by BIOMARIN PHARMACEUTICAL INC.. The full Galsulfase monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02412683
Brand name
NAGLAZYME
Active ingredient
Galsulfase
Strength
1 MG
Dosage form
SOLUTION
Route
INTRAVENOUS
Manufacturer
BIOMARIN PHARMACEUTICAL INC.
Health Canada status
MARKETED
Drug class
Enzyme replacement therapy (recombinant N-acetylgalactosamine 4-sulfatase)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.